• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用TFX(胸腺因子X)治疗系统性红斑狼疮的可能性]

[Possibility of using TFX (thymus factor X) in the treatment of systemic lupus erythematosus].

作者信息

Lasisz B, Zdrojewicz Z, Dul W, Markiewicz A, Strychalski J

出版信息

Pol Tyg Lek. 1989;44(30-31):724-5.

PMID:2701749
Abstract

A case of a 32-year female patient with the systemic lupus erythematosus is presented. The patient was treated with prednisone in a daily dose of 40-60 mg. Due to the exacerbations of the symptoms and advanced renal disorders, the patient was given TFX together with corticotherapy. Thymus factor X is an extract of real thymus of immunorecorrective properties. It specifically acts on the lymphatic system, especially disordered mechanisms of both cellular and humoral immunity. Thymus factor X was given in the dose of 10 mg (one ampoule) i.m. for the three first months followed by one ampoule every three days for the next three months. The patient is given one ampoule of TFX once a week since the 6th months of therapy. Diminishment of the symptoms was observed. The patient is in remission since a one-year follow-up period. It was also possible to reduce the dose of prednisone to 15 mg a day. The patient is controlled every 3 months. Partial normalization of renal functioning and immunological mechanisms are seen. A decrease in antinuclear antibodies and immunoglobulins, normalization in complement components, an increase in T-cells percentage and conversion of the delayed skin reaction are noted. The authors conclude that TFX may be helpful in the treatment of the autoimmunological diseases, including the systemic lupus erythematosus.

摘要

本文介绍了一例32岁的系统性红斑狼疮女性患者。该患者接受泼尼松治疗,每日剂量为40 - 60毫克。由于症状加重和严重的肾脏疾病,患者在接受皮质激素治疗的同时给予了胸腺因子X(TFX)。胸腺因子X是具有免疫纠正特性的真正胸腺提取物。它特异性作用于淋巴系统,尤其是细胞免疫和体液免疫的紊乱机制。最初三个月,胸腺因子X的给药剂量为10毫克(一支),肌肉注射,之后的三个月每三天注射一支。自治疗的第6个月起,患者每周注射一支TFX。观察到症状有所减轻。经过一年的随访期,患者处于缓解状态。同时也有可能将泼尼松的剂量减至每日15毫克。每3个月对患者进行一次检查。可见肾功能和免疫机制部分恢复正常。抗核抗体和免疫球蛋白减少,补体成分恢复正常,T细胞百分比增加,迟发性皮肤反应转为阳性。作者得出结论,TFX可能有助于治疗自身免疫性疾病,包括系统性红斑狼疮。

相似文献

1
[Possibility of using TFX (thymus factor X) in the treatment of systemic lupus erythematosus].[使用TFX(胸腺因子X)治疗系统性红斑狼疮的可能性]
Pol Tyg Lek. 1989;44(30-31):724-5.
2
[Clinical effectiveness of the treatment of systemic lupus erythematosus with preparations of the methylxanthine group and T-activin].[甲基黄嘌呤类制剂和T-激活素治疗系统性红斑狼疮的临床疗效]
Klin Med (Mosk). 1987 Jan;65(1):107-11.
3
High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.系统性红斑狼疮中不进行干细胞移植的大剂量环磷酰胺治疗
Arthritis Rheum. 2003 Jan;48(1):166-73. doi: 10.1002/art.10752.
4
[Comparison of treatment outcome in patients with rheumatoid arthritis treated with TFX- Polfa or gold salts after a one year follow up].
Pol Tyg Lek. 1992;47(49-50):1102-4.
5
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.系统性红斑狼疮患者认知功能障碍的预测因素
Neurology. 2005 Jan 25;64(2):297-303. doi: 10.1212/01.WNL.0000149640.78684.EA.
6
[Letter: Antinuclear autoimmunization in Swan mice. Prevention and regression by treatment with thymosin].
Nouv Presse Med. 1975 Feb 15;4(7):507.
7
[Clinical trial of the treatment of rheumatoid arthritis with TFX (thymus factor X)].[用TFX(胸腺因子X)治疗类风湿性关节炎的临床试验]
Wiad Lek. 1990;43(17-18):870-3.
8
The course of anticardiolipin antibody levels under immunoadsorption therapy.免疫吸附治疗下抗心磷脂抗体水平的变化过程。
Am J Kidney Dis. 2005 Sep;46(3):446-54. doi: 10.1053/j.ajkd.2005.05.023.
9
Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.血清可溶性白细胞介素-2受体作为某些自身免疫性疾病中淋巴细胞活化的标志物。免疫抑制治疗的效果。
Roum Arch Microbiol Immunol. 2001 Jul-Sep;60(3):183-201.
10
[Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].[静脉注射免疫球蛋白治疗系统性红斑狼疮:文献综述与初步临床经验]
Infusionsther Transfusionsmed. 1993 Apr;20 Suppl 1:131-5; discussion 136.